Publication | Closed Access

305 Twelve weeks of neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation (CRT) and total mesorectal excision (TME) in MRI defined poor risk locally advanced rectal cancer resulted in promising tumour regression and rapid symptomatic relief

Neuro-oncologySurgical OncologyPoor RiskRadiation TherapyGastrointestinal OncologyColorectal SurgeryMedicineColorectal CancerTwelve WeeksSurgeryPromising Tumour RegressionCancer TreatmentOncologyRadiation OncologyRadiologyHealth Sciences